ReviewInternational journal of medical sciences2026
Bioengineering modification and application of bacterial outer membrane vesicles.
Review in International journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Role of bacterial outer membrane vesicles in immune evasion during infection.Archives of microbiology · 2026Review
- [Preparation of HLYVSPW peptide-displaying outer membrane vesicles and validation of their in vitro targeting effects on triple-negative breast cancer cells].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2026Article
- Chimeric biohybrid nanovesicles induce immunogenic cell death for targeted and immune-potentiated glioblastoma therapy.Asian journal of pharmaceutical sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Outer Membrane Vesicles (OMVs) are spherical nanovesicles naturally secreted by Gram-negative bacteria, playing key roles in nutrient uptake, toxin delivery, and the transmission of drug resistance. Recent studies have increasingly focused on the clinical potential of OMVs. Due to their remarkable biocompatibility and immunogenic properties, OMVs offer wide-ranging applications in vaccine development and antigen/drug delivery, showing great promise in the treatment of tumors, autoimmune diseases, and infections. However, challenges remain in standardizing the production and modification of OMVs, limiting their broader application. This review consolidates research on OMV modification and application, aiming to provide valuable insights to advance the development of OMV-based therapeutic strategies and clinical implementations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.